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Objectives: To explore the accuracy of the Cornell Assessment for Pediatric Delirium (CAP-D), and 
the Pediatric- and Preschool- versions of the Confusion Assessment Method for the Intensive Care 
Unit (pCAM-ICU and psCAM-ICU) when implemented into routine care as a screening tool; and, 
assess patient characteristics and clinical variables which may affect their validity. 
Design: A prospective observational study. 
Setting: A 36-bed, mixed-PICU at an Australian tertiary hospital. 
Patients: Critically ill children developmentally aged 6 months to 17 years with a PICU length of stay 
≥ 18 hours. 
Interventions: None. 
Measurements and Main Results: Patients were screened for delirium by their bedside nurse (CAP-
D and pCAM-ICU/psCAM-ICU) once daily, for up to five days. Delirium status identified using 
screening instruments was compared to delirium diagnosis using the diagnostic criteria for Delirium 
(DSM-5). In this sample, the CAP-D retained its high sensitivity (91.3%) and good specificity (75.2%), 
whereas the psCAM-ICU and pCAM-ICU had moderate sensitivity (58.8% and 75.0%, respectively) 
and excellent specificity (89.8% and 84.9%, respectively). There was moderate agreement between 
the CAP-D and the psCAM-ICU, κ = .52, p < .001; and good agreement between the CAP-D and the 
pCAM-ICU, κ = .80, p < .01. 
Conclusions: Although the CAP-D, psCAM-ICU and pCAM-ICU all appear promising in their validation 
studies, when implemented into routine care, their performance can be variable. The CAP-D 
performed well in routine clinical practice, but follow-up diagnosis is required to confirm delirium. 
The ps/pCAM-ICU both provide valuable, objective assessments of delirium in critically ill children, 
however further evaluation of their implementation into routine clinical practice is needed. 
 
 






Delirium is a serious neuropsychiatric complication of critical illness characterised by acute and 
fluctuating disturbances in attention and awareness, and changes in baseline cognition. 1 Paediatric 
delirium is common in children admitted to the Paediatric Intensive Care Unit (PICU), occurring in 
25% of patients, 2 and has been associated with increased health-care expenditure, length of 
hospitalisation, duration of mechanical ventilation and risk of mortality. 3-5 Emerging research in 
adults has linked the early prevention, identification and management of delirium with reduced 
burden on nursing workload. 6 Diagnosing delirium in children is challenging, however, as it requires 
clinicians to consider multiple factors (e.g., developmental regression, pain, anxiety, depression, 
iatrogenic withdrawal and psychosis) that may have a similar or comorbid presentation. 7, 8 The 
variation in developmental age and cognitive and language skills in children admitted to PICU, 
combined with the speculation that there is no lower age limit to delirium, further complicates 
paediatric delirium detection. Additionally, the availability of personnel, patient needs, and the 
feasibility of implementing time- and resource-intensive evaluation of symptoms against the 
Statistical Manual of Mental Disorders (DSM-5) diagnostic criteria, adds to the difficulty of delirium 
diagnosis. 9 As such, clinical decision-making relies on the use of delirium screening instruments that 
address all of the aforementioned challenges. 
Rapid and reliable screening of paediatric delirium is important in aiding accurate identification, 10 
ongoing assessment and re-assessment (including confirming delirium status with follow-up 
diagnosis), 8 and prevention and management strategies (e.g., implementing multi-component non-
pharmacological interventions). 11 Accurate screening instruments are also necessary for better 
understanding the prevalence, risk factors, and outcomes of paediatric delirium. 12 In recognition 
that bedside nurses are uniquely placed to detect symptoms of delirium and instigate early 
prevention, identification and management strategies, 13, 14 there has been an increase in the 
availability screening instruments that have been developed and validated for use at the PICU 
bedside with minimal training, including: the Cornell Assessment for Pediatric Delirium (CAP-D), 15-17 
 3 
the Pediatric Confusion Assessment Method for the Intensive Care (pCAM-ICU), 18 and the Preschool 
Confusion Assessment Method for the Intensive Care Unit (psCAM-ICU) . 19 While all three 
instruments are reliable and rapid tools for detecting delirium, they have primarily been validated 
when employed by trained users; the CAP-D was initially validated with the attending paediatric 
intensivist and chief resident, 15 while the pCAM-ICU and psCAM-ICU were validated by a study team 
of trained paediatric anaesthesiologists, intensivists, nurse practitioners and registered nurses. 18, 19 
Only the CAP-D has undergone validity testing with bedside nurses undertaking the screening 
assessment, however, this have yet to be replicated outside the developing institution. 17 To date, 
this has facilitated standardisation of these screening instruments but does not ensure accuracy 
when used for routine bedside screening. 
Additionally, few studies have accounted for patient and clinical variables that may impact the 
accuracy of delirium screening instruments. Factors such as receiving sedation, mechanical 
ventilation, age and gender have been shown to impact the accuracy of the pCAM-ICU and its 
modified severity scale (sspCAM-ICU), 20 while others have also speculated that developmental 
delay, younger age and motoric subtype can all complicate the accuracy of delirium detection. 7, 9, 17 
Therefore, this study aimed to i) evaluate the accuracy of each screening instrument, when 
implemented into routine care, against a reference standard assessment of delirium (clinical 
diagnosis using the DSM-5 criteria); 1 and, ii) assess patient characteristics and clinical variables 
which may affect their validity. 
MATERIAL AND METHODS 
Study Design and Participants 
This prospective, observational study was conducted from November 2015 to April 2017 in a 36 bed,  
mixed medical and surgical PICU at an Australian tertiary hospital. The study was undertaken 12 
months after commencing nursing education and the adoption of routine delirium screening using 
the ps/pCAM-ICU and CAP-D. This study was granted ethics approval by the Children’s Health 
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Queensland Human Research Ethics Committee (HREC/13/QRCH/105/AM4) and the University of 
Queensland Human Research Ethics Committee (2015001425). 
Inclusion Criteria 
All patients developmentally aged 6 months to 17 years were eligible for inclusion. As the patient’s 
age impacted the decision regarding which paediatric CAM-ICU used, developmental age was based 
on parent or bedside nurse report regarding the patient’s capacity at baseline to complete the 
psCAM-ICU (6 months to 5 years) or the pCAM-ICU (≥6 years). Therefore, when (according to parent 
or bedside nurse report) a patient’s developmental age was less than their chronical age, they were 
categorised as “developmentally delayed” but included in the study. 
Exclusion Criteria 
Patients were excluded if they had significantly impaired vision or hearing which prevented 
completion of the ps/pCAM-ICU; were comatose or deeply sedated (State Behavioral Scale, SBS, 
score <-1); had significant intellectual impairment or developmental delay (developmentally <6 
months); were receiving end-of-life care; were admitted <18 hours; were under the care of the 
Department of Child Safety; or their parents were non-English speaking. 
Recruitment, Consent and Study Procedures 
On consecutive weekdays for 18 months, patients were screened daily for eligibility to participate in 
the study. Assessment of delirium could only be performed in patients with a SBS score ≥-1, 21 
indicating the patient was sufficiently aware for delirium assessment. If a patient’s SBS was too low 
for assessment (-2, -3), they were reviewed daily to determine their eligibility for inclusion in the 
study. In order to include patients who transited from deep sedation to awake states, all patients 
were evaluated for inclusion, even if they met exclusion criteria the previous day (e.g., due to being 
deeply sedated). Parents or guardians of eligible patients were approached to participate in the 
study. When informed consent was obtained, paired assessment commenced. Enrolled patients 
underwent paired assessments (a nurse evaluation using the CAP-D and the ps/pCAM-ICU and a 
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reference standard evaluation using the DSM-5 diagnostic criteria) at 12:00pm to align with routine 
screening. Consistent with Smith and colleagues, 18 paired assessments occurred within three hours. 
All assessors were blinded to the findings of each other’s evaluations. Eligible patients were re-
evaluated for delirium over consecutive days for the remainder of their PICU admission. To reduce 
potential response bias, and consistent with other studies, 18 assessments were capped at a 
maximum of five paired assessments per patient. 
Nursing Education 
Delirium screening education was provided through a mandatory online in-service that included a 
video series providing paediatric delirium education (e.g., symptoms, risk factors, management 
strategies), specific demonstrations of administering the CAP-D, pCAM-ICU and psCAM-ICU 
(including scenarios where assessment may be challenging, e.g., non-compliant, low arousal), and a 
test of their knowledge at the end of the online training. Overall, 83.4% of nursing staff (n = 191) 
completed the education series, with additional bedside training undertaken by a member of the 
research team. A convenience sample of ten paired CAP-D and p/psCAM-ICU assessments between 
the bedside nurse and research nurse providing the education session indicated acceptable 
interrater reliability (κ  =0.62-1.00). 22 Further education was provided through bedside education 
maintenance and mandatory competency days. 
Instruments 
Index tests 
To evaluate the accuracy of screening in routine clinical practice, each assessment was undertaken 
by the patient’s bedside nurse. For children developmentally <6 years old, the nurse screened 
patients using the psCAM-ICU and the CAP-D, while children developmentally ≥6 years old, were 
screened for delirium using the pCAM-ICU and CAP-D. 
The CAP-D is modified from the Pediatric Assessment of Emergence Delirium (PAED) scale to capture 
hypoactive, hyperactive and mixed motoric symptoms. 15, 23 The scale includes eight items which 
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assessors score based on the frequency of symptoms over the course of a shift (‘Never’, ‘Rarely’, 
‘Sometimes’, ‘Often’, and ‘Always’). For children ≤2 years old, the instrument is accompanied by a 
validated rubric of developmental anchor points. 16 Patients who score a total ≥9 are considered 
delirium positive. 
The structure of the ps/pCAM-ICU is modified from the CAM-ICU to enable developmentally 
appropriate evaluation, 24, 25 and comprises four features: (A) acute onset or fluctuating course of 
altered mental status, (B) inattention, (C) altered level of consciousness, and (D) disorganised 
thinking. For very young children (psCAM-ICU), the assessment for inattention is completed using 
developmentally appropriate picture cards and a mirror. Similarly, picture cards can be used as an 
attentional test in older children, however assessment using the pCAM-ICU commonly incorporates 
a modified Vigilance ‘A’ test, 26 and evaluates disorganised thinking by asking children to respond to 
questions and commands, rather than looking for evidence of subtle neuropsychiatric symptoms 
(e.g., non-purposeful movement, inconsolability) and dysregulated systems and behaviour (psCAM-
ICU). Both the psCAM-ICU and pCAM-ICU are considered delirium positive if the patient 
demonstrates disturbances in features A and B, and feature C and/or D. 
Overall, the instruments either require (psCAM-ICU and pCAM-ICU) or do not require (CAP-D) 
patient interaction; are point-in-time (psCAM-ICU and pCAM-ICU) or require reflection of 
observations over several hours (CAP-D); all take <2 minutes to complete. The psychometric 
properties of the CAP-D, pCAM-ICU and psCAM-ICU are described in Table 1, with each instrument 
demonstrating acceptable sensitivity and specificity in previous validation studies. 17-19 
Reference Standard Assessment 
The reference standard assessments were based on a clinical diagnosis by a graduate-level 
psychologist (author RP) with experience in PICU and hospitalised children more broadly, in 
accordance with the DSM-5 diagnostic criteria for delirium. 1 The reference standard assessor 
underwent training with a Clinical Psychologist and Neuropsychologist, and consulted with a 
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delirium assessment expert (Dr Gabrielle Silver), prior to commencing assessment. Information was 
collected from parents or guardians, bedside nursing staff, medical staff, and medical charts, and 
documented on a checklist of the five diagnostic criterion and associated features. Diagnosis was 
supported by a diagnostic aide (to be published), similar to the Vanderbilt Assessment for Delirium 
in Infants and Children (VADIC), 27 which included age- and developmentally-specific examples of 
paediatric disturbances in attention and awareness, cognition, sleep-wake cycle, emotional 
responsivity, and psychomotor activity. A clinical decision was made based on observations and 
collateral information, with consideration of alternative causes for changes from baseline attention 
and awareness. Reference standard assessments took approximately 10-30 minutes to complete. 
When an assessment was recorded as ‘delirium present’, a delirium subtype (hypoactive, 
hyperactive or mixed) was ascribed. There is no consensus on the definition of subsyndromal 
delirium (SSD), 28 so if an assessment was recorded as ‘delirium absent’, a classification of ‘SSD 
present’ was made if Criterion B (a disturbance “which develops over a short period of time”, and 
which “represents a change from baseline attention and awareness”) 1, and at least two other 
criteria were met. 
Statistical Analysis 
Statistical analysis for evaluating measurement properties was guided by the COnsensus-based 
Standards for the selection of health Measurement INstruments (COSMIN) Risk of Bias checklist 29 
and is reported according to the Standards for Reporting Diagnostic accuracy studies (STARD) 2015 
checklist. 30 Demographic characteristics are summarized using descriptive statistics. Statistical 
analyses were performed using the IBM SPSS Version 25 for Mac (IBM Statistics, Chicago, Illinois). 31 
Power calculations 
In order to calculate the required sample size to determine the validity of each screening 
instrument, we adopted a H0 of 50.0% sensitivity and specificity for each screening instrument. As 
the instruments were being evaluated as screening, not diagnostic, instruments, we prioritised 
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greater sensitivity over specificity when determining the minimum target sensitivity (Ha = 80.0) and 
specificity (Ha = 70.0) required, with a = .05, 1-b = .80. Based on the reported delirium incidence of 
12.3% to 44.0% in previous validation studies, 15-19 we conservatively anticipated a 20% prevalence 
of delirium in our population. Therefore to achieve target sensitivity, we estimated a total sample 
size of 100 assessments were required. 32 
Predictive validity 
The psychometric properties of the three screening instruments were determined by their predictive 
ability to classify patients into ‘delirium present’ or ‘delirium absent’ categories compared to the 
DSM-5 reference standard diagnosis. The number of true positives, false positives, true negatives 
and false negatives were calculated using 2 x 2 tables. Predictive validity was evaluated by 
calculating sensitivity (true positive/(true positive + false negative)); specificity (true negative/(false 
positive + true negative)); positive predictive value (PPV) (true positive/(true positive + false 
positive)); and negative predicative value (NPV) (true negative/(true negative + false negative)). 
Values greater than 0.70 (moderate) were pre-specified as acceptable. Accuracy of the three 
screening instruments was derived from the area under the curve (AUC) using Receiver Operator 
Characteristic (ROC) Curves, with scores ³0.70 considered acceptable. 33 
Construct validity 
Convergent validity was established by comparing delirium state (present/absent) between nurse 
assessments of the CAP-D and the ps/pCAM-ICU using Cohen’s kappa statistics, as it can account for 
the variation in dichotomous outcomes due to chance alone.34 Based on the assumption that the 
CAP-D and the ps/pCAM-ICU both measure delirium in critically ill children, it was hypothesised that 
the instruments would demonstrate k > 0.65 (moderate) agreement. 22 Divergent validity by 
comparing nurse assessments of delirium using the CAP-D and the ps/pCAM-ICU to the child’s 
concurrent Multidimensional Assessment of Pain Scale (MAPS) score, 35 using Cohen’s kappa. It was 
assumed that the instruments measure distinct constructs (delirium versus pain), and hypothesised 
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that there would be k < 0.40 (low) agreement. 22 
Covariate effects on screening accuracy 
Disagreement between tests was determined by calculating the discordance between the index text 
outcome and the reference standard outcome ([index text outcome – reference test outcome]; 
disagreement = |1|, agreement = 0) and agreement evaluated using Cohen’s kappa. Univariate and 
multivariate analysis using logistic regression was undertaken to identify patient- and treatment-
related variables that contributed to the likelihood of disagreement. Based on a review of the 
literature, these included patient age, gender, developmental delay, illness severity (Paediatric index 
of mortality 3; PIM-3), mechanical ventilation status (mechanical ventilation required versus not 
required), sedation status (receiving sedation versus not receiving sedation), subsyndromal delirium 
(present versus absent), delirium subtype (hypoactive versus mixed/hyperactive subtypes), and time 
between paired assessments. Variables that were significant at the univariate level (p < .10) were 
included in the multivariate analysis. To control for responder bias in patients with prolonged 
admissions, the multivariate analyses included PICU length of stay. 
RESULTS 
Patient Characteristics 
In total, 119 patients were enrolled and 186 reference standard assessments were conducted. Five 
patient assessments were excluded due to >180 minutes separating the nursing assessment from 
the reference standard, and 18 reference assessments were missing corresponding index tests (see 
Figure 1 for participant flow diagram). 30 Patient characteristics are described in Table 2. The 
majority of patients were female (n = 64; 54.0%) and had a primary diagnosis of ‘Surgical, excluding 
cardiac’ (n = 35, 29.4%). The median length of PICU stay was 2.5 (IQR = 1.8–6.6) days. The first paired 
assessment occurred on PICU admission day 2.0 (IQR = 1.0–5.0 days) and participants had a median 
of 1.0 (IQR = 1.0-2.0) study assessments. On average, the reference and index tests occurred within 
30:33 (Mdn = 31:00, IQR = 15:00-60:00) minutes of each other. According to DSM-5 criteria, 22.6% of 
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all reference assessments (n = 42) were ‘delirium present’ (hypoactive n = 20, 47.6%; hyperactive n = 
10, 23.8%; and mixed n = 12, 28.6%), and 38.3% assessments (n = 72) were ‘SSD present’. 
Criterion validity 
The criterion validity of the screening instruments is summarised in Table 3 and included 176 CAP-D 
assessments (93.1%), 125 psCAM-ICU assessments (66.1%) and 38 pCAM-ICU assessments (21.6%). 
Positive CAP-D results show delirium was correctly in 21/23 assessments (sensitivity = 91.3%) and 
negative results show absence of delirium was correctly identified 115/117 assessments (specificity 
= 75.2). The PPV and NPV of the CAP-D were 35.6% and 98.3% respectively. Delirium positive scores 
on the psCAM-ICU indicated that delirium was correctly identified in 10/17 assessments, resulting in 
a sensitivity of 58.8% (NPV = 93.3%). Negative results demonstrated that absence of delirium was 
correctly identified by the psCAM-ICU in 97/104 patients, resulting in a specificity of 89.8% (PPV = 
47.6%). Positive assessments using the pCAM-ICU showed that delirium was correctly detected in 
3/4 assessments, yielding a sensitivity of 75.0% (PPV = 37.5%); negative assessments indicated that 
the absence of delirium was correctly identified 28/33 assessments, resulting in a specificity of 
84.9% (NPV = 96.6%). The ROC Curve analysis is summarised in Figure 2 and shows an AUC of 0.74 
for the psCAM-ICU (p = .001), 0.80 for the pCAM-ICU (p = .051), and 0.83 for the CAP-D (p < .001), 
when compared to the DSM-5 diagnostic criteria for delirium (Table 3). 
Construct validity 
Convergent validity was evaluated using paired assessments of the CAP-D and psCAM-ICU (n = 125) 
and the CAP-D and pCAM-ICU (n = 38). There was moderate to good agreement between the CAP-D 
and psCAM-ICU assessments, κ  = 0.52 (95% CI, 0.37 to 0.67), p < .001; and the CAP-D and pCAM-ICU 
assessments, κ = 0.80 (95% CI, 0.58 to 1.0), p < .001, respectively. 
Divergent validity was evaluated using paired assessments of the CAP-D and MAPS (n = 166), the 
psCAM-ICU and MAPS (n = 94) and the pCAM-ICU and MAPS (n = 35). There was very low agreement 
for both the CAP-D, κ  = 0.27 (95% CI, -0.13 to 0.42), p < .001, and the psCAM-ICU, κ  = 0.23 (95% CI, -
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0.15 to 0.40), p = .009, when compared to the MAPS. For the pCAM-ICU, there was moderate 
agreement with the MAPS, κ  = 0.41 (95% CI, -0.29 to 0.78), p = .001 
Covariate effects on screening accuracy 
A total of 40 CAP-D (22.7%; κ = .40 [95% CI, 0.26 to 0.54], p < .001), 18 psCAM-ICU (10.2%; κ = .44 
[95% CI, 0.22 to 0.66], p < .001) and 6 pCAM-ICU (16.2%; κ = .42 [95% CI, 0.05 to 0.79], p < .01) 
assessments were discordant to the reference standard assessment. At the univariate level, CAP-D 
disagreement was associated with younger age (p = .015), receiving any sedation (p = .001), and SSD 
(p < .001). Disagreement with the psCAM-ICU was marginally associated with younger age (p = .052) 
and receiving sedation (p = .031). Factors such as time between paired assessments, mechanical 
ventilation status, developmental delay, and motoric subtype were not associated with likelihood of 
disagreement for the CAP-D and psCAM-ICU (p > .10). The number of discordant assessments for the 
pCAM-ICU were too small to determine any significant variables which may contribute to inaccuracy 
at the univariate level. 
The multivariate model exploring disagreement between the reference standard and the CAP-D is 
summarised in Table 4. The regression model (𝛘2(4) = 38.0, p < .001) indicated an increased 
likelihood of an inaccurate result when patients were younger (OR = 0.9, p = .013), receiving any 
sedation (OR = 4.1, p = .006) or met SSD criteria (OR = 4.4, p = .001). The number of discordant 
assessments for the psCAM-ICU were too small to determine any significant variables which may 
contribute to inaccuracy at the multivariate level. 
DISCUSSION 
To the best of our knowledge, this current study is the first to evaluate the accuracy of paediatric 
delirium screening instruments implemented into routine care. This study found that the CAP-D was 
highly sensitive, with results similar to its validation studies, 15, 16 and had reasonable specificity. The 
pCAM-ICU had sensitivity scores slightly lower than previously reported, but maintained excellent 
specificity. 18, 20 Conversely, the psCAM-ICU was not as sensitive as previously reported 19, despite 
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excellent specificity. 
Although the psCAM-ICU was not as sensitive as expected, it is likely that this is a reflection of lower 
than predicted delirium prevalence, 32 especially compared to its validation study. 19 The structure of 
the psCAM-ICU may have additionally contributed to its reduced sensitivity in this setting. In 
particular, the first step of the psCAM-ICU is to determine an “acute change or fluctuating course of 
mental status”, which if absent, results in the assessment being discontinued and the patient scored 
as ‘delirium negative’. Determining changes in mental status in critically ill infants and young 
children is difficult due to the large variations in language and cognitive development in this cohort, 
as highlighted by the univariate association between younger age and reduced psCAM-ICU accuracy. 
This association is only tenuous and does not account for co-occurring factors, however future 
implementation of the psCAM-ICU into routine clinical practice may benefit from the 
accompaniment of developmentally appropriate guidance for detecting altered mental status in this 
challenging cohort. 
Overall, the corresponding PPV for each of the screening instruments was low compared to other 
studies. 12, 17-19 Again, this can be partially explained by the low prevalence of delirium (10.8% to 
13.6%) which can have a significant impact on PPV and NPV values. 38 It is also possible that the 
determination of delirium “present” for each instrument could be improved, as false positives for 
each instrument were high compared to true positives. In considering how to determine delirium 
“present” however, consideration of the purpose of delirium screening and the context in which 
screening occurs is important. Ideally, diagnostic instruments should return high PPV values. 39 Yet, if 
the aim of a screening instrument is to identify as much delirium as possible (i.e., be highly 
sensitive), particularly when paediatric delirium is consistently described as under-recognised, a 
lower PPV balanced by a high NPV is appropriate. 40 
This study found acceptable convergent validity between each of the screening instruments, 
indicating that they are measuring similar constructs. However, this was lower than expected 
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between the CAP-D and the psCAM-ICU. This may be reflective of the challenges associated with 
detecting symptoms of delirium in young children, especially as both the CAP-D and psCAM-ICU 
appeared to be affected by this at the univariate level. It is also possible that disparity in the design 
of the two instruments, particularly in how both instruments evaluate attention and awareness, and 
disorganised thinking, contributed to differences observed. Conversely, both the CAP-D and the 
psCAM-ICU, and to a lesser degree the pCAM-ICU, were able to demonstrate acceptable ability in 
differentiating between delirium and pain as distinct constructs. That there is some small overlap 
between a delirium screening instrument and symptoms of pain is not surprising however, as 
similarities in symptom presentation between the two constructs has previously been discussed. 7, 8 
Delirium screening instruments are invaluable for detecting changes in attention, awareness and 
cognition, but are not diagnostic tools, and ‘delirium positive’ scores should always be followed up 
by clinical review. This was underscored by the acceptable but comparatively low indices of 
agreement with the reference standard, 15-19 potentially reflecting the variable performance of these 
instruments when not conducted by expert members of a research team. Alternatively, each of the 
screening instruments were compared to the DSM-5 diagnostic criteria for delirium while previous 
studies used the DSM-IV diagnostic criteria as the reference standard. The impact of differences in 
how delirium is measured between the two editions of the DSM therefore cannot be ruled out, 
especially as research in the adult literature indicates that the two editions can result in discordant 
assessments. 41 
This study is not without limitations. We made diligent attempts to consent every eligible patient to 
the study, but were unable to do so. As a result, our sample is skewed towards patients with lower 
acuity and the first assessment occurring later in admission, and consequently there is potential that 
those children who were missed had a higher prevalence of delirium. Although this may limit 
generalisability of the study’s results to the entire PICU, arguably this sample is representative of the 
PICU population for which delirium assessment is most feasible. It is also possible that the 
concurrent screening using the CAP-D and ps/pCAM-ICU influenced and biased the results of both 
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nursing assessments. However, as the CAP-D is an indicator of delirium symptoms over a period of 
time (in this study, over 6 hours) while , conversely, the ps/pCAM-ICU measure delirium at a point-
in-time, the risk of the results biasing the other is low. Additionally, we included up to five daily 
paired assessments, on the basis that delirium is a disorder characterised by rapidly developing and 
fluctuating symptoms. As the majority of participants only had one assessment per admission, we 
did not adjust for repeated measures, however the potential for repeated-measures bias is a 
limitation of the current study. Finally, the lower sample size of ps/pCAM-ICU assessments hindered 
concurrent evaluation of the screening instruments, which limits the scope of making direct 
comparisons between the instruments. 
A major strength of this study was the inclusion of end-users in the validation of the three 
instruments in this population. Previously, validation of the CAP-D and the ps/pCAM-ICU has 
primarily relied on trained, expert users, restricting the interpretation of those results for routine 
clinical use. Future research is required to directly compare the accuracy and feasibility of each of 
these tools, evaluate their use in other medical settings (e.g., general hospital wards, oncology) and 
extend comparison to other promising screening instruments not available at the time of conducting 
this study (i.e., the SOS-PD). 42 
CONCLUSIONS 
To date, limited research that evaluates paediatric screening instruments outside of their developing 
centres exists. This prospective observational study aimed to evaluate the psychometric 
performance of three delirium screening instruments: the CAP-D, the psCAM-ICU and the pCAM-ICU 
as part of routine clinical practice. As a screening instrument, the CAP-D performs well, though all 
patients with ‘delirium positive’ screens should be closely monitored, with follow-up diagnosis 
required to confirm delirium. The ps/pCAM-ICU both provide valuable, objective assessments of 
delirium in critically ill children, but may benefit from an accompanying diagnostic aide, similar to 
the CAP-D, to guide their use in very young children or children with developmental delay. Given the 
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variation of these results and previous research, further evaluation of their implementation into 
routine clinical practice is needed.  
 16 
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Sensitivity 94.1% (84.0-99.0) 78.0% (75.0-80.0) 78.0% (40.0-97.0) 
Specificity 79.2% (74.0-85.0) 86.0% (84.0-88.0) 98.0% (91.0-99.9) 
PPV 54.0% (44.0-64.0) 78.0% (75.0-80.0) 88.0% (51.0-99.9) 
NPV 98.0% (94.0-99.6) 86.0% (85.0-88.0) 97.0% (88.0-99.8) 
 
 
Figure 1. Participant flow diagram for all assessments included in analysis. *Potentially eligible 
accounts for all daily presentations over the 18 month study period; aComatose refers to any patient 
with an SBS < -1 or with a GCS < 8 in patients who were not receiving sedation; bUnder the care of 
the Department of Child Services; cNESP = Non-English speaking parent; dOther – Long-term patient 
previously declined;  eNot consented – Primarily referred to patient discharged before approached 
for consent (81.5%). 
 
TABLE 2. Demographic and Clinical Characteristics of Participants 
aSES derived from the Australian Bureau of Statistics Index of Relative Socio-economic Advantage 
and Disadvantage percentile scores26; b Reported at assessment level for entire sample (Total n = 
186); cDay 0 is first day of admission 
 
Patient Characteristics (n =119) n (% total) 
Demographics  
Age at admission, years (mdn, IQR) 3.5 (1.2 – 10.9) 
Gender (Female) 64 (54.0%) 
Developmental Delay / Intellectual Impairment 13 (10.9%) 
Socio-economic status (SES)a (mdn percentile rank, IQR) 59.0 (35.3 – 75.0) 
Primary diagnosis  
Surgical (excl. cardiac) 35 (29.4%) 
Respiratory  26 (21.8%) 
Cardiovascular (incl. post-op) 21 (17.6%) 
Gastrointestinal/Renal 21 (17.6%) 
Neurologic 10 (8.4%) 
Injury 3 (2.5%) 
Other 21 (17.6%) 
PICU Course  
Paediatric Index of Mortality (PIM-3) score, at discharge (mdn, IQR) 0.6 (0.2 – 1.1) 
Length of mechanical Ventilation, hours (mdn, IQR)   5.25 (0.0 – 59.5) 
Mechanical Ventilation (Yes) 71 (59.7%) 
PICU Length of Stay, days (mdn, IQR) 2.5 (1.8 – 6.6) 
Outcomes  
Overall delirium prevalence (reference standard)b 42 (22.6%) 
Level of sedation, SBS Score (mdn, IQR) 0.0 (0.0 – 1.0) 
Number of Assessments (mdn; IQR) 1.0 (1.0 – 2.0) 
Day of admission at time of first assessment (mdn, IQR)c 2.0 (1.0-5.0) 
Time between reference and index tests, minutes (mdn, IQR) 31:00 (15:00 – 60:00) 
In hospital mortality 1 (0.8%) 
TABLE 3. Predictive validity of delirium screening assessments by instrument 
Properties 
CAP-D (n = 176) 
(95% CI) 
psCAM-ICU (n= 125) 
(95% CI) 
pCAM-ICU (n = 38) 
(95% CI) 
Absent Present Absent Present Absent Present 
Positive Reference 2 21 7 10 1 3 
Negative Reference 115 38 97 11 28 5 
Prevalence a 23 (13.1%) 17 (13.6%) 4 (10.8%) 
Sensitivity 91.3 (72.0-98.3) 58.8 (32.9-81.6) 75.0 (19.4-99.4) 
Specificity 75.2 (67.5-82.0) 89.8 (82.5-94.8) 84.9 (68.1-98.9) 
PPV 35.6 (29.0-42.8) 47.6(31.4-64.4) 37.5 (18.3-61.7) 
NPV 98.3 (93.8-99.5) 93.3 (88.7-96.1) 96.6 (83.6-99.4) 
AUC 83.2 (75.2-91.3)** 74.3 (59.6-89.0)* 80.1 (54.2-100.0) 
* = p-value < .01; ** = p-value < .001; a Reported prevalence rate based on subsample of 
reference standard assessments paired with a corresponding screening instrument. 
 
Figure 2. ROC Curve analysis plotting sensitivity and specificity of the screening instrument against 
the reference standard (the diagonal); (A) CAP-D (AUC = .83, p < .001); (B) psCAM-ICU (AUC = .74, p = 




TABLE 4. Logistic Regression predicting discordance between delirium diagnosis and 
screening instrument outcome. 





CAP-Da         
PICU LOSb 0.001 0.001 3.0 1 .102 1.0 1.0 1.0 
Age -0.1 0.04 6.2 1 .013 0.9 1.0 1.2 
Sedation -1.4 0.5 7.5 1 .006 4.1 1.5 11.5 
SSD  -1.5 0.5 10.7 1 .001 4.4 1.8 10.5 
Note. OR = odds ratio; SSD refers to Subsyndromal Delirium; sedation (currently receiving 
any sedation, yes/no) is absent compared to present; SSS is absent compared to present. 
aNagelkerke R2 =0.3, 𝛘2(4) = 38.0, p < .001; bPICU length of stay (LOS) entered into the model 
as control variable.  
 
